Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 0.32
HH's Cash-to-Debt is ranked higher than
53% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. HH: 0.32 )
Ranked among companies with meaningful Cash-to-Debt only.
HH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.32  Med: 5029.8 Max: No Debt
Current: 0.32
Equity-to-Asset -0.20
HH's Equity-to-Asset is ranked lower than
97% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HH: -0.20 )
Ranked among companies with meaningful Equity-to-Asset only.
HH' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.2  Med: 0.73 Max: 0.91
Current: -0.2
-0.2
0.91
Piotroski F-Score: 4
Altman Z-Score: -16.59
Beneish M-Score: -4.47
WACC vs ROIC
14.90%
-190.93%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -21.11
HH's Operating Margin % is ranked lower than
95% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. HH: -21.11 )
Ranked among companies with meaningful Operating Margin % only.
HH' s Operating Margin % Range Over the Past 10 Years
Min: -50.4  Med: -17.51 Max: 0.14
Current: -21.11
-50.4
0.14
Net Margin % -30.12
HH's Net Margin % is ranked lower than
94% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. HH: -30.12 )
Ranked among companies with meaningful Net Margin % only.
HH' s Net Margin % Range Over the Past 10 Years
Min: -79.5  Med: -29.71 Max: 0.89
Current: -30.12
-79.5
0.89
ROA % -63.47
HH's ROA % is ranked lower than
99% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. HH: -63.47 )
Ranked among companies with meaningful ROA % only.
HH' s ROA % Range Over the Past 10 Years
Min: -70.56  Med: -24.26 Max: 2.59
Current: -63.47
-70.56
2.59
ROC (Joel Greenblatt) % -375.71
HH's ROC (Joel Greenblatt) % is ranked lower than
96% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. HH: -375.71 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -392.94  Med: -53.07 Max: 6.95
Current: -375.71
-392.94
6.95
3-Year Revenue Growth Rate -9.70
HH's 3-Year Revenue Growth Rate is ranked lower than
87% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. HH: -9.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -50.6  Med: -9.7 Max: 10.6
Current: -9.7
-50.6
10.6
3-Year EBITDA Growth Rate -31.50
HH's 3-Year EBITDA Growth Rate is ranked lower than
90% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. HH: -31.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -31.5  Med: -3.9 Max: 19.1
Current: -31.5
-31.5
19.1
3-Year EPS without NRI Growth Rate -25.60
HH's 3-Year EPS without NRI Growth Rate is ranked lower than
83% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. HH: -25.60 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -12.45 Max: 76.5
Current: -25.6
0
76.5
GuruFocus has detected 4 Warning Signs with Hooper Holmes Inc $HH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

HH Guru Trades in Q1 2016

Jim Simons 1,198,300 sh (+7.67%)
» More
Q2 2016

HH Guru Trades in Q2 2016

Jim Simons 91,229 sh (+14.20%)
» More
Q3 2016

HH Guru Trades in Q3 2016

Jim Simons 91,729 sh (+0.55%)
» More
Q4 2016

HH Guru Trades in Q4 2016

Jim Simons 63,329 sh (-30.96%)
» More
» Details

Insider Trades

Latest Guru Trades with HH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 524291    SIC: 6411
Compare:OTCPK:PFHO, OTCPK:WNDM, OTCPK:QNIIF, OTCPK:SPIN, OTCPK:LMNK, OTCPK:CPAI, OTCPK:FDNH, AMEX:SSY, OTCPK:JRSS, OTCPK:BICX, OTCPK:GRST, OTCPK:USNU, OTCPK:CAMDF, OTCPK:ATMS, OTCPK:GNOW, OTCPK:CVHIF, AMEX:AMS, OTCPK:BNKL, OTCPK:CCEL, NYSE:ADPT » details
Hooper Holmes Inc provides on-site health screenings, laboratory testing, risk assessment and sample collection services to individuals as part of comprehensive health and wellness programs offered through corporate and government employers.

Hooper Holmes provides medical and other underwriting information on insurance policy applicants to life and health insurance companies. Through its network of more than 300 offices in the United States, the company provides medical examinations, personal health interviews, medical record collection, and laboratory testing, which help insurance companies evaluate the risks associated with their underwriting policies. Hooper Holmes has more than 700 insurance company customers.

Ratios

vs
industry
vs
history
PS Ratio 0.20
HH's PS Ratio is ranked higher than
94% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. HH: 0.20 )
Ranked among companies with meaningful PS Ratio only.
HH' s PS Ratio Range Over the Past 10 Years
Min: 0.06  Med: 0.44 Max: 5.58
Current: 0.2
0.06
5.58
Current Ratio 0.45
HH's Current Ratio is ranked lower than
92% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. HH: 0.45 )
Ranked among companies with meaningful Current Ratio only.
HH' s Current Ratio Range Over the Past 10 Years
Min: 0.45  Med: 2.58 Max: 7.23
Current: 0.45
0.45
7.23
Quick Ratio 0.38
HH's Quick Ratio is ranked lower than
92% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.16 vs. HH: 0.38 )
Ranked among companies with meaningful Quick Ratio only.
HH' s Quick Ratio Range Over the Past 10 Years
Min: 0.38  Med: 2.53 Max: 7.23
Current: 0.38
0.38
7.23
Days Inventory 13.33
HH's Days Inventory is ranked higher than
59% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 18.84 vs. HH: 13.33 )
Ranked among companies with meaningful Days Inventory only.
HH' s Days Inventory Range Over the Past 10 Years
Min: 5.19  Med: 11.02 Max: 42.22
Current: 13.33
5.19
42.22
Days Sales Outstanding 44.25
HH's Days Sales Outstanding is ranked lower than
51% of the 174 Companies
in the Global Medical Care industry.

( Industry Median: 44.22 vs. HH: 44.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
HH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.67  Med: 46.1 Max: 280.61
Current: 44.25
40.67
280.61
Days Payable 91.36
HH's Days Payable is ranked higher than
66% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. HH: 91.36 )
Ranked among companies with meaningful Days Payable only.
HH' s Days Payable Range Over the Past 10 Years
Min: 14.15  Med: 46.22 Max: 162.88
Current: 91.36
14.15
162.88

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -29.10
HH's 3-Year Average Share Buyback Ratio is ranked lower than
88% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. HH: -29.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -29.1  Med: -0.7 Max: 0.3
Current: -29.1
-29.1
0.3

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.44
HH's Price-to-Median-PS-Value is ranked higher than
92% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. HH: 0.44 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.19  Med: 2.3 Max: 7.53
Current: 0.44
0.19
7.53
Earnings Yield (Greenblatt) % -64.45
HH's Earnings Yield (Greenblatt) % is ranked lower than
99% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.94 vs. HH: -64.45 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -65.06  Med: 5.55 Max: 8.3
Current: -64.45
-65.06
8.3
Forward Rate of Return (Yacktman) % 545.99
HH's Forward Rate of Return (Yacktman) % is ranked higher than
99% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 10.02 vs. HH: 545.99 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -0.8  Med: -0.2 Max: 545.99
Current: 545.99
-0.8
545.99

More Statistics

Revenue (TTM) (Mil) $34.27
EPS (TTM) $ -1.18
Beta1.40
Short Percentage of Float1.91%
52-Week Range $0.65 - 2.70
Shares Outstanding (Mil)12.16
» More Articles for HH

Headlines

Articles On GuruFocus.com
Arquitos Capital Management Q1 2015 Investor Letter May 01 2015 
Hooper Holmes Inc Reports Operating Results (10-Q) Nov 05 2010 
Hooper Holmes Inc Reports Operating Results (10-Q) Aug 06 2010 
Hooper Holmes Inc Reports Operating Results (10-Q) May 07 2010 
Hooper Holmes Inc Reports Operating Results (10-Q) Nov 06 2009 
Hooper Holmes Inc (HH) CEO Roy H Bubbs buys 50,000 Shares Aug 14 2009 
Hooper Holmes Inc Reports Operating Results (10-Q) Aug 07 2009 
Hooper Holmes Inc (HH) CEO Roy H Bubbs buys 25,326 Shares Jun 01 2009 
Hooper Holmes Inc (HH) CEO Roy H Bubbs buys 31,577 Shares May 29 2009 
Hooper Holmes Inc Reports Operating Results (10-Q) May 09 2009 

More From Other Websites
HOOPER HOLMES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 22 2017
HOOPER HOLMES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 20 2017
Hooper Holmes Files 2016 Annual Report on Form 10-K and Form S-4 Regarding Proposed Merger with... Mar 20 2017
Henry E. Dubois, CEO of Hopper Holmes Inc., (NYSE: HH) to Present at The MicroCap Conference on... Mar 20 2017
Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Hooper Holmes, Inc. - HH Mar 17 2017
Hooper Holmes, Inc. :HH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017 Mar 16 2017
Dr. Robin Smith Joins Hooper Holmes as a Board Advisor Mar 16 2017
HOOPER HOLMES INC Financials Mar 15 2017
Hooper Holmes, Inc. :HH-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
HOOPER HOLMES INC Files SEC form 10-K, Annual Report Mar 09 2017
Blog Coverage Hooper Holmes Acquires Privately Held Health and Wellness Company Provant Health... Mar 09 2017
HOOPER HOLMES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD... Mar 08 2017
Olathe wellness company merges with Rhode Island peer Mar 08 2017
Hooper Holmes and Provant to Merge Mar 08 2017
Hooper Holmes Expands into Mental Health with MYnd Analytics Dec 28 2016
Hooper Holmes Expands into Mental Health with MYnd Analytics Dec 28 2016
HOOPER HOLMES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 06 2016
Hooper Holmes to Present at the 9th Annual LD Micro Main Event Nov 29 2016
HOOPER HOLMES INC Files SEC form 8-K, Entry into a Material Definitive Agreement Nov 18 2016
HOOPER HOLMES INC Files SEC form 10-Q, Quarterly Report Nov 15 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)